PCSK9 Inhibitors and Managing Cost in the Managed Care SettingBySheila L. Stadler, PharmD, BCPS-AQ Cardiology, CLS,Thomas J. Cook, PhD, RPhJune 21st 2017
Epidemiology and Management of HyperlipidemiaBySamantha Karr, PharmD, FCCP, BCPS, BCACP, BC-ADMJune 21st 2017
